Research and Markets(http://www.researchandmarkets.com/research/fc8dda/south_and_central) has announced the addition of Global Markets Direct's new report "South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" to their offering.
Executive Summary:
South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020
Global Markets Direct's new report "South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" provides in-depth analysis of the South and Central American Active Pharmaceutical Ingredients (API) market and presents revenue forecasts up to 2020 for Mexico and Brazil. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base - generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole South and Central American market is also covered in the report.
Economic Crisis Slows the Revenue Growth of the South and Central American API Market
The current global economic crisis has negatively affected the South and Central American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings in healthcare expenditure, there is a shift away from the high-priced innovative drugs in Mexico and Brazil. This has resulted in a significant slowdown in the revenue growth of the South and Central American API market. In 2009, the South and Central American API market is set to grow at a rate of around 2%.
Brazil Set to Overtake Mexico in the South and Central American API Market by 2020
The Brazilian API market, the second largest market in South and Central America, is set to overtake Mexico in its revenue share by 2020. The Brazilian API market is characterized by an emerging biotech API product segment which is the fastest growing in the South and Central American market. Adding to this, the Brazilian pharmaceutical industry is strong and growing at a healthier rate than Mexico and other countries. This higher growth is set to enable the Brazilian API market to gain revenue share during the period 2008-2020. By 2020, Brazil is expected to hold a revenue share of around 30% and Mexico around 28%.
Biotech APIs Set to Drive the Overall Growth of the API Market in South and Central America
The biotech API market in South and Central America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for biological drugs is boosting the demand for the biotech API in the market place. In addition, the technological advancement in the pharmaceutical industry is paving the way for newer biotechnology drugs. This will boost the growth of the biotech API market making it grow at a rate which is significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 7% from 2008 to 2020.